NEW YORK (GenomeWeb News) – Biocrates Life Sciences said today that it has forged a worldwide co-marketing agreement with Applied Biosystems focused on the metabolomics market.
 
Innsbruck, Austria-based Biocrates will promote ABI’s mass spectrometers for targeted metabolomics and for use in combination with its AbsoluteIDQ kits. In return, ABI will promote Biocrates’ AbsolteIDQ kits for targeted metabolomics in combination with its triple quadrupole and QTRAP series instruments.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.